Apollo to Present at the Bernstein Strategic Decisions Conference
Get Alerts APO Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.6%
EPS Growth %: +14.1%
Join SI Premium – FREE
NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”), announced today that Marc Rowan, Co-Founder and Senior Managing Director, will present at the Bernstein Strategic Decisions Conference on Thursday, May 28, 2020 at 1:00 p.m. ET.
A live audio webcast of the presentation will be available on the Stockholders section of Apollo’s website at https://www.apollo.com/stockholders. For those unable to listen to the live audio webcast, a replay will be available on Apollo’s website shortly after the event.
About Apollo
Apollo is a leading global alternative investment manager with offices in New York, Los Angeles, San Diego, Houston, Bethesda, London, Frankfurt, Madrid, Luxembourg, Mumbai, Delhi, Singapore, Hong Kong, Shanghai and Tokyo. Apollo had assets under management of approximately $316 billion as of March 31, 2020 in credit, private equity and real assets funds invested across a core group of nine industries where Apollo has considerable knowledge and resources. For more information about Apollo, please visit www.apollo.com.
Contact Information
For investor inquiries regarding Apollo:
Gary M. Stein
Head of Investor Relations
Apollo Global Management, Inc.
212-822-0467
[email protected]
Ann Dai
Investor Relations Manager
Apollo Global Management, Inc.
212-822-0678
[email protected]
For media inquiries regarding Apollo:
Joanna Rose
Global Head of Corporate Communications
Apollo Global Management, Inc.
(212) 822-0491
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Urbanica Furniture Simplifies Office Setup with Customizable Workspace Bundles
- Ninepoint Partners Announces July 2026 Cash Distributions for its ETFs and ETF Series Securities
- Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share